The association of IL-6 with poor outcome has been demonstrated in many conditions such as HIV [35], many cancers [36], and occurrence of vascular disease including stroke [37], making it more plausible that IL-6 is a general marker of disease severity rather than part of numerous disease-specific pathways to poor outcome. This evidence concerns the gene IL6 and stroke disorder.